Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).
Authors
Anthony B. El-Khoueiry
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA;
Anthony B. El-Khoueiry , Marwan Fakih , Michael S. Gordon , Apostolia Maria Tsimberidou , Andrea J. Bullock , Breelyn A. Wilky , Jonathan C. Trent , Kim Allyson Margolin , Daruka Mahadevan , Ani Sarkis Balmanoukian , Rachel E. Sanborn , Gary K. Schwartz , Bruno Bockorny , Justin C Moser , Joseph Elan Grossman , Waldo Ignacio Ortuzar Feliu , Katherine Rosenthal , Steven O'Day , Heinz-Josef Lenz , Benjamin L. Schlechter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03860272
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr LBA8)
DOI
10.1200/JCO.2023.41.4_suppl.LBA8
Abstract #
LBA8
Poster Bd #
A1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Biomarker analysis to predict response in patients with metastatic mismatch repair proficient colorectal cancer treated with regorafenib and nivolumab.
First Author: Ruoyu Miao
First Author: Sandra Algaze
Poster
2019 Gastrointestinal Cancers Symposium
Retrospective analysis of clinical characteristics of mCRC patients receiving three or more lines of chemotherapy.
First Author: Pilar Garcia Alfonso
Poster
2015 ASCO Annual Meeting
Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial.
First Author: Pierre Laurent-Puig